Closed End Fund Advisors Inc. bought a new position in abrdn Healthcare Investors (NYSE:HQH – Free Report) in the 4th quarter, HoldingsChannel reports. The institutional investor bought 39,603 shares of the financial services provider’s stock, valued at approximately $750,000.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Wolverine Asset Management LLC purchased a new stake in shares of abrdn Healthcare Investors during the fourth quarter worth about $2,780,000. Atlantic Union Bankshares Corp purchased a new stake in shares of abrdn Healthcare Investors during the third quarter worth about $178,000. Geneos Wealth Management Inc. grew its position in shares of abrdn Healthcare Investors by 9,232.3% during the second quarter. Geneos Wealth Management Inc. now owns 2,893 shares of the financial services provider’s stock worth $45,000 after purchasing an additional 2,862 shares in the last quarter. Prevail Innovative Wealth Advisors LLC grew its position in shares of abrdn Healthcare Investors by 65.9% during the second quarter. Prevail Innovative Wealth Advisors LLC now owns 103,537 shares of the financial services provider’s stock worth $1,604,000 after purchasing an additional 41,143 shares in the last quarter. Finally, Ameriprise Financial Inc. grew its position in shares of abrdn Healthcare Investors by 7.6% during the second quarter. Ameriprise Financial Inc. now owns 347,070 shares of the financial services provider’s stock worth $5,372,000 after purchasing an additional 24,492 shares in the last quarter. 32.60% of the stock is currently owned by institutional investors and hedge funds.
abrdn Healthcare Investors Trading Down 0.8%
NYSE:HQH opened at $19.11 on Friday. abrdn Healthcare Investors has a 12-month low of $15.09 and a 12-month high of $20.46. The stock has a 50-day moving average price of $19.34 and a 200 day moving average price of $19.13.
abrdn Healthcare Investors Dividend Announcement
abrdn Healthcare Investors Company Profile
abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.
The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.
Further Reading
- Five stocks we like better than abrdn Healthcare Investors
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Want to see what other hedge funds are holding HQH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for abrdn Healthcare Investors (NYSE:HQH – Free Report).
Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
